Doransamine Capsule (Anemia)

1) Efficacy, effect

1. Bleeding tendency believed to be related to systemic hyperfibrinolysis (leukemia, aplastic anemia, purpura, cancer, etc., and abnormal bleeding during and after surgery)
2. Abnormal bleeding thought to be related to local hyperfibrinolysis (pulmonary bleeding, genital bleeding, renal bleeding, abnormal bleeding during or after prostate surgery)

2) Usage, dosage

(capsule)
Tranexamic acid is usually administered orally at 750 to 2000 mg per day in 3 to 4 divided doses for adults.
Increase or decrease appropriately depending on age and symptoms.

3) Packaging unit

30 capsules/bottle

4) Ingredients, content

Tranexamic Acid Tranexamic Acid 250mg

5) Period of use

36 months from date of manufacture

6) Storage method

Airtight container, stored at room temperature (1~30°C)